Analyst Expectations For Celldex Therapeutics's Future
Analyst Expectations For Celldex Therapeutics's Future
塞德斯醫療未來的分析師期望
In the preceding three months, 5 analysts have released ratings for Celldex Therapeutics (NASDAQ:CLDX), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $77.4, a high estimate of $80.00, and a low estimate of $67.00. This current average has not changed from the previous average price target.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Celldex Therapeutics is derived...
登入免費觀看全文
登入/註冊